Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 2 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Recs

0
Player Avatar ahabswife (23.76) Submitted: 5/28/2008 3:20:06 PM : Outperform Start Price: $4.73 NBIX Score: +38.64

I've said it before and I will say it again, drugs are good.

Featured Broker Partners


Advertisement